AngioDynamics Inc (ANGO)

Currency in USD
13.16
-0.48(-3.52%)
Closed·
13.37+0.21(+1.60%)
·
Earnings results expected in 8 days
ANGO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.1413.60
52 wk Range
8.2713.99
Key Statistics
Prev. Close
13.64
Open
13.54
Day's Range
13.14-13.6
52 wk Range
8.27-13.99
Volume
315.17K
Average Volume (3m)
523.43K
1-Year Change
48.53%
Book Value / Share
4.4
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ANGO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
19.33
Upside
+46.91%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

AngioDynamics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

AngioDynamics Company Profile

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company’s thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers’ off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

AngioDynamics Inc Earnings Call Summary for Q1/2026

  • Q1 FY2026 revenue of $75.7M, up 12.2% YoY, beating forecasts. EPS of -$0.10 surpassed expectations. Stock surged 17.43% premarket.
  • Med-tech segment revenue grew 26.1%. Mechanical thrombectomy showed strong performance. Gross margin increased to 55.3%.
  • FY2026 guidance revised: net sales $308-$313M (5-7% growth), adjusted EBITDA $6-$10M, adjusted loss per share to improve to -$0.33 to -$0.23.
  • CEO highlighted growth across all business areas. CFO noted Auryon's 17 consecutive quarters of double-digit YoY growth.
  • Analysts focused on mechanical thrombectomy growth drivers, Ambition BTK trial progress, and sales force expansion plans.
Last Updated: 02/10/2025, 14:16
Read Full Transcript

Compare ANGO to Peers and Sector

Metrics to compare
ANGO
Peers
Sector
Relationship
P/E Ratio
−16.9x−1.1x−0.6x
PEG Ratio
−0.200.370.00
Price/Book
3.0x0.9x2.6x
Price / LTM Sales
1.8x1.7x3.2x
Upside (Analyst Target)
32.0%23.0%41.8%
Fair Value Upside
Unlock5.1%5.1%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 19.33
(+46.91% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Canaccord Genuity
Buy18.00+36.78%-Maintain25/11/2025
H.C. Wainwright
Buy16.00+21.58%-Maintain06/10/2025
Canaccord Genuity
Buy18.00+36.78%17.00Maintain03/10/2025
H.C. Wainwright
Buy16.00+21.58%-Maintain17/07/2025
Lake Street Capital Markets
Buy24.00+82.37%-New Coverage16/07/2025

Earnings

Latest Release
Oct 02, 2025
EPS / Forecast
-0.10 / -0.12
Revenue / Forecast
75.70M / 72.70M
EPS Revisions
Last 90 days

People Also Watch

21.73
IMNM
-1.36%
603.54
CVCO
+0.33%
35.240
LQDA
-1.51%
29.21
UPB
-4.01%

FAQ

What Is the AngioDynamics (ANGO) Share Price Today?

The live AngioDynamics share price today is 13.16

What Stock Exchange Does AngioDynamics (ANGO) Trade On?

AngioDynamics is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for AngioDynamics?

The stock symbol (also called a 'ticker') for AngioDynamics is "ANGO."

What Is the Current AngioDynamics Market Cap?

As of today, AngioDynamics market capitalisation is 542.19M.

What Is AngioDynamics's (ANGO) Earnings Per Share (TTM)?

The AngioDynamics EPS is currently -0.78 (Trailing Twelve Months).

When Is the Next AngioDynamics Earnings Date?

AngioDynamics's next earnings report will be released on 01 Jan 2026.

Is ANGO a Buy or Sell From a Technical Analyst Perspective?

Based on today's AngioDynamics moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has AngioDynamics Stock Split?

AngioDynamics has split 0 times. (See the ANGO stock split history page for full effective split date and price information.)

How Many Employees Does AngioDynamics Have?

AngioDynamics has 675 employees.

What is the current trading status of AngioDynamics (ANGO)?

As of 24 Dec 2025, AngioDynamics (ANGO) is trading at a price of 13.16, with a previous close of 13.64. The stock has fluctuated within a day range of 13.14 to 13.60, while its 52-week range spans from 8.27 to 13.99.

What Is AngioDynamics (ANGO) Price Target According to Analysts?

The average 12-month price target for AngioDynamics is USD19.33333, with a high estimate of USD24 and a low estimate of USD16. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +46.91% Upside potential.

What Is the ANGO After Hours Price?

ANGO's last after hours stock price is 13.37, the stock has decreased by 0.21, or 1.60%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.